Tele-Navigation of Lung Cancer Screening (Tele-Navi LCS)
- Conditions
- Lung Cancer
- Registration Number
- NCT05021133
- Lead Sponsor
- University of Massachusetts, Worcester
- Brief Summary
Adherence to annual follow up is critical to achieving mortality benefits and optimizing cost-effectiveness of lung cancer screening (LCS). However, adherence to LCS follow-up in the real world is suboptimal. Using telehealth, the investigators will co-create Tele-Navigation of Lung Cancer Screening with patients and LCS stakeholders as an intervention to promote adherence of follow-up LCS. The investigators will then implement the Tele-Navi LCS intervention to a pilot sample of patients and evaluate its feasibility in the primary care setting. The investigators will measure the number of patient participants who completed Tele-Navi LCS and follow-up LCS within 180 days from Tele-Navi LCS.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 22
- Is eligible for LDCT for LCS follow-up
- Has technology to complete study activities (e.g., video call visit)
- English speaker
- Has undergone LCS at UMMH
- Is overdue for LDCT follow-up
- Has previous diagnosis of lung cancer
- Has active cancer diagnosis
- Is a nursing home or group care resident
- Is pregnant
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Completion of Tele-Navi LCS 30 days Number of participants completed Tele-Navi LCS,
- Secondary Outcome Measures
Name Time Method Completion of Follow-up LCS 180 days Number of participants who received a low-dose CT (LDCT) for LCS follow-up
Trial Locations
- Locations (1)
UMass Chan Medical School
🇺🇸Worcester, Massachusetts, United States
UMass Chan Medical School🇺🇸Worcester, Massachusetts, United States